Prognostic Implications for High Expression of MiR-25 in Lung Adenocarcinomas of Female Non-smokers |
Xu, Fang-Xiu
(Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer)
Su, Yu-Liang (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer) Zhang, Huan (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer) Kong, Jin-Yu (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer) Yu, Herbert (Epidemiology Program, University of Hawaii Cancer Center) Qian, Bi-Yun (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer) |
1 | Salmena L, Carracedo A, Pandolfi P P (2008). Tenets of PTEN tumor suppression. Cell, 133, 403-14. DOI ScienceOn |
2 | Qiang L, Zou C, Zou C, et al (2013). MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Letters, 335, 168-74. DOI ScienceOn |
3 | Raben D, Helfrich B, Bunn P A, Jr. (2004). Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. Int J Radiat Oncol Biol Phys, 59, 27-38. DOI ScienceOn |
4 | Rudin C M, Avila-Tang E, Harris C C, et al (2009). Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res, 15, 5646-61. DOI ScienceOn |
5 | Scapoli L, Palmieri A, Lo Muzio L, et al (2010). MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol, 23, 1229-34. |
6 | Shen J, Todd N, Zhan H, et al (2011 ). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.Lab Invest, 91, 579-87. DOI ScienceOn |
7 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
8 | Suh SS, Yoo JY, Nuovo GJ, et al (2012). MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci USA, 109, 5316-21. DOI |
9 | Toh C K, Gao F, Lim W T, et al (2006). Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol, 24, 2245-51. DOI ScienceOn |
10 | Toh CK, Lim WT (2007). Lung cancer in never-smokers. J Clin Pathol, 60, 337-40. |
11 | Manning BD, Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell, 129, 1261-74. DOI ScienceOn |
12 | Liu N, Chen NY, Cui RX, et al (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol, 13, 633-41. DOI ScienceOn |
13 | Li Y, Tan W, Neo TW, et al (2009). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci, 100, 1234-42. DOI ScienceOn |
14 | Lynch TJ, Bell DW, Sordella R, et al (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med, 350, 2129-39. DOI ScienceOn |
15 | Pallis AG, Syrigos KN (2013). Lung cancer in never smokers: Disease characteristics and risk factors. Crit Rev Oncol Hematol, 88, 494-503. DOI ScienceOn |
16 | Metayer C, Wang Z, Kleinerman R A, et al (2002). Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer, 35, 111-7. DOI ScienceOn |
17 | Min K, Li Y, Liu W, et al (2013 ). miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.Int J Mol Med 32, 51-8. |
18 | Myong NH (2004). Reduced expression of E-cadherin in human non-small cell lung carcinoma.Cancer Res Treat, 36, 56-61. DOI ScienceOn |
19 | Pao W, Miller V, Zakowski M, et al (2004). EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Current Issue, 101, 13306-11 |
20 | Poliseno L, Salmena L, Riccardi L, et al (2010). Identification of the miR-106b-25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its HostGene MCM7 in Transformation. Sci Signal, 3, 1-26. |
21 | Ciuffreda LMJ, Milella M (2009). Signaling intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK pathways) as therapeutic targets for anti-cancer and anti angiogenesis treatments. Curr Signal Transduct Ther, 4, 130-43. DOI |
22 | Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. DOI ScienceOn |
23 | Chen Q, Si Q, Xiao S, et al (2013). Prognostic significance of serum miR-17-5p in lung cancer. Med Oncol, 30, 353. DOI ScienceOn |
24 | Franchina T, Amodeo V, Bronte G, et al (2013). Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. J Cell Physiol, 229, 97-9. |
25 | Ciuffreda L, Di Sanza C, Cesta Incani U, et al (2012). The mitogen-activated protein kinase (MAPK) cascadecontrols phosphatase and tensin homolog (PTEN)expression through multiple mechanisms. J Mol Med, 90, 667-79. DOI ScienceOn |
26 | Dacic S, Kelly L, Shuai Y, Nikiforova MN (2010). miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol, 2 3, 1577-82. DOI ScienceOn |
27 | Esposito F, Tornincasa M, Pallante P, et al (2012). Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab, 97, 710-8. DOI ScienceOn |
28 | Garofalo M, Jeon YJ, Nuovo GJ, et al (2013). MiR-34a/c-Dependent PDGFR-alpha/beta Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLoS One, 8, 675-81. |
29 | Lewis BP, Shih IH, Jones-Rhoades MW, et al (2003). Prediction of mammalian microRNA targets.Cell, 115, 787-98. DOI ScienceOn |
30 | Bartel DP(2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI ScienceOn |
31 | Besson A, Dowdy SF, Roberts JM (2008). CDK inhibitors: cell cycle regulators and beyond. Dev Cell, 14, 159-69. DOI ScienceOn |
32 | Yang L, Tan W, Neo T, et al (2009). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci, 100, 1234-42. DOI ScienceOn |
33 | Zhu W, Liu X, He J, et al (2011b). Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study. BMC Cancer, 11, 392-402. DOI |
34 | Yeh Y, Chuang C, Chao K, Wang L ( 2013). MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1. Int J Cancer, 133, 867-78. DOI ScienceOn |
35 | Zhang H, Zuo Z, Lu X, et al (2012). MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.Oncol Rep, 27, 594-8. |
36 | Zhu L, Yan W, Rodriguez-Canales J, et al (2011a). MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. Am J Cancer Res, 1, 574-84. |
37 | Wu X, Ajani J A, Gu J, et al (2013). MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila), 6, 196-205. DOI ScienceOn |
38 | Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61. DOI ScienceOn |
39 | Wakelee HA, Chang ET, Gomez SL, et al (2007). Lung cancer incidence in never smokers. J Clin Oncol, 25, 472-8. DOI ScienceOn |
40 | Wang Y, Li Z, He C, et al (2010). MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis, 44, 191-7. DOI ScienceOn |
41 | Xu X, Chen Z, Zhao X, et al (2012). MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun, 421, 640-5. DOI ScienceOn |
42 | Yang K, Zhao W, Xiong J, Cao R (2013). Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. FEBS Lett, 587, 3153-7. DOI ScienceOn |
43 | Kim B H, Hong S W, Kim A, et al (2013). Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol, 107, 505-10. DOI ScienceOn |
44 | Thun MJ, Hannan LM, Adams-Campbell LL, et al (2008). Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 5, e185. DOI ScienceOn |
![]() |